{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:13:48Z","timestamp":1790435628600,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T00:00:00Z","timestamp":1256169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9333-6","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T11:51:41Z","timestamp":1256125901000},"page":"1057-1059","source":"Crossref","is-referenced-by-count":13,"title":["Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report"],"prefix":"10.1007","volume":"27","author":[{"given":"Keith","family":"Siau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,22]]},"reference":[{"key":"9333_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"2","author":"W Symmers","year":"1952","unstructured":"Symmers W. Thrombotic microangiopathic haemolytic anaemia (Thrombotic microangiopathy). Br Med J. 1952;2:897\u2013903.","journal-title":"Br Med J"},{"key":"9333_CR2","first-page":"271","volume-title":"Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, (Kidney Disease S v. 10)","author":"AJ Murgo","year":"1992","unstructured":"Murgo AJ. Cancer- and chemotherapy-associated thrombotic microangiopathy. In: Kaplan BS, Trompeter RS, Moake JL, editors. Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, (Kidney Disease S v. 10), vol. 22. New York: Marcel Dekker Ltd; 1992. p. 271\u201395."},{"issue":"5","key":"9333_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","volume":"3","author":"JE Cantrell Jr","year":"1985","unstructured":"Cantrell JE Jr, Phillips TM, Schein PS. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985;3(5):723\u201334.","journal-title":"J Clin Oncol"},{"issue":"2","key":"9333_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","volume":"8","author":"JS Dlott","year":"2004","unstructured":"Dlott JS, Danielson CFM, Blue-Hnidy DE, McCarthy LJ. Drug-induced thrombotic thrombocytopenic purpura\/haemolytic uremic syndrome: a concise review. Ther Apher Dial. 2004;8(2):102\u201311.","journal-title":"Ther Apher Dial"},{"issue":"5","key":"9333_CR5","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19930301)71:5<1882::AID-CNCR2820710527>3.0.CO;2-E","volume":"71","author":"HW Snyder Jr","year":"1993","unstructured":"Snyder HW Jr, Mittelman A, Oral A, Messerschmidt GL, et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 1993;71(5):1882\u201392.","journal-title":"Cancer"},{"issue":"7","key":"9333_CR6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajh.21439","volume":"84","author":"HT Ling","year":"2009","unstructured":"Ling HT, Field JJ, Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol. 2009;84(7):418\u201321.","journal-title":"Am J Hematol"},{"issue":"2","key":"9333_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jvir.2008.10.025","volume":"20","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, Engel JM, Clouse LH, Gerndt KM. Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab. Vasc Interv Radiol. 2009;20(2):275\u20136.","journal-title":"Vasc Interv Radiol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9333-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9333-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:41Z","timestamp":1559427761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9333-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,22]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9333"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9333-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,22]]}}}